Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Dane Stevens

Tracked across 9 events · 103 articles · First seen Jan 26, 2026 · Last active Sep 23, 2026

Sentiment
26
Attention
4
Events
9
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Dane Stevens, CEO of Optimi Health, highlighted the significance of the production and export runs in expanding access to psychedelic treatments in Australia.
Jan 26, 2026 · 6 articles
4 60
Business
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health, is leading the company's ibogaine initiative and highlights the growing interest and public funding for ibogaine research.
Jun 08, 2026 · 14 articles
4 60
Tech
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health Corp., announced the launch of the new microdose psilocybin products, highlighting their consistent dosage for controlled research.
Jun 16, 2026 · 11 articles
4 50
Business
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health, highlighted the significance of the company's first shipment to the United Kingdom and its unique position as a vertically integrated GMP supplier.
Jun 02, 2026 · 25 articles
2 5
Business
Impact: Dane Stevens will support Sean Ladley in the Charlotte office, overseeing Cohen & Company Capital Markets' preferred sales and trading team with deep expertise in preferred securities.
Jun 08, 2026 · 7 articles
4 0
Business
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health, expressed pride in the company's commercial supply of psilocybin and highlighted Australia's role as a model for regulated psychedelic medicine.
Jun 29, 2026 · 12 articles
2 0
Tech
Optimi Health announced plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with major depressive disorder. The trial, authorized by Canada — Health Canada, will enroll up to 200 participants…
Impact: As CEO and Co-Founder of Optimi Health, Dane Stevens announced the trial and emphasized its strategic importance. His leadership is tied to the company's clinical development strategy.
Sep 10, 2026 · 15 articles
1 0
Business
Optimi Health, a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, announced the appointment of Michael Blough, Ph.D., as its Chief Clinical Development Officer, a newly created position. Dr. Blough has worked with Optimi on…
Impact: As CEO and co-founder, he announced and commented on the appointment, highlighting its importance for the company's clinical trials.
Sep 22, 2026 · 7 articles
1 0
Business
Optimi Health announced on September 8, 2026 that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14-16, 2026 at the Lotte New York Palace Hotel in New…
Impact: Dane Stevens is identified as CEO of Optimi Health and the investor contact for the company; he is not reported to have a specific speaking role at the conference.
Sep 08, 2026 · 6 articles
Optimi Health ceo ↔ Dane Stevens Dane Stevens is the Chief Executive Officer and Co-Founder of Optimi Health, a c
Optimi Health ↔ Dane Stevens
Australia ↔ Dane Stevens
Australia ↔ Dane Stevens
Canada ↔ Dane Stevens
Canada ↔ Dane Stevens
ERGEN INTELLIGENCE
Track Dane Stevens live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.